Oncotarget

Vol 11, No 15

April 14, 2020

View Archive »

Order a Reprint

About The Cover

The cover for issue 15 of Oncotarget features Figure 6, "Tumor growth suppression effect represented by tumor size and changes in body weight in C6 glioma and GL261 allograft mice after the injection of para-211At-phenylalanine (PA) (*p < 0.05 compared to the control).," by Watabe, et al.

Table of Contents

Research Perspectives

Zebrafish B cell acute lymphoblastic leukemia: new findings in an old model

Zebrafish B cell acute lymphoblastic leukemia: new findings in an old model

https://doi.org/10.18632/oncotarget.27555

Gilseung Park, Jessica Burroughs-Garcia, Clay A. Foster, Ameera Hasan, Chiara Borga,  and J. Kimble Frazer
1292-1305
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Research Papers

Pirfenidone anti-fibrotic effects are partially mediated by the inhibition of MUC1 bioactivation

Pirfenidone anti-fibrotic effects are partially mediated by the inhibition of MUC1 bioactivation

https://doi.org/10.18632/oncotarget.27526

Beatriz Ballester, Javier Milara,  and Julio Cortijo
1306-1320
Abstract  |  PDF  |  Full Text  |  How to cite  |  Press Release  |  Order a Reprint

Association of germline genetic variants with TMPRSS2-ERG fusion status in prostate cancer

Association of germline genetic variants with TMPRSS2-ERG fusion status in prostate cancer

https://doi.org/10.18632/oncotarget.27534

Indu Kohaar, Qiyuan Li, Yongmei Chen, Lakshmi Ravindranath, Denise Young, Amina Ali, Isabell A. Sesterhenn, Inger L. Rosner, Jennifer Cullen, Shiv Srivastava, Matthew Freedman,  and Gyorgy Petrovics
1321-1333
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

A phase II study of axalimogene filolisbac for patients with previously treated, unresectable, persistent/recurrent loco-regional or metastatic anal cancer

A phase II study of axalimogene filolisbac for patients with previously treated, unresectable, persistent/recurrent loco-regional or metastatic anal cancer

https://doi.org/10.18632/oncotarget.27536

Cathy Eng, Marwan Fakih, Manik Amin, Van Morris, Howard S. Hochster, Patrick M. Boland,  and Hope Uronis
1334-1343
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Molecular imaging reveals biodistribution of P-cadherin LP-DART bispecific and trafficking of adoptively transferred T cells in mouse xenograft model

Molecular imaging reveals biodistribution of P-cadherin LP-DART bispecific and trafficking of adoptively transferred T cells in mouse xenograft model

https://doi.org/10.18632/oncotarget.27544

Vijay R. Gupta, Adam Root, Timothy Fisher, Rand Norberg, John David, Tracey Clark, Justin Cohen, Chad May,  and Anand Giddabasappa
1344-1357
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Gene expression dynamic analysis reveals co-activation of Sonic Hedgehog and epidermal growth factor followed by dynamic silencing

Gene expression dynamic analysis reveals co-activation of Sonic Hedgehog and epidermal growth factor followed by dynamic silencing

https://doi.org/10.18632/oncotarget.27547

Vahed Maroufy, Pankil Shah, Arvand Asghari, Nan Deng, Rosemarie N.U. Le, Juan C. Ramirez, Ashraf Yaseen, W. Jim Zheng, Michihisa Umetani,  and Hulin Wu
1358-1372
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Superior cancer preventive efficacy of low versus high dose of mTOR inhibitor in a mouse model of prostate cancer

Superior cancer preventive efficacy of low versus high dose of mTOR inhibitor in a mouse model of prostate cancer

https://doi.org/10.18632/oncotarget.27550

Marina P. Antoch, Michelle Wrobel, Bryan Gillard, Karen K. Kuropatwinski, Ilia Toshkov, Anatoli S. Gleiberman, Ellen Karasik, Michael T. Moser, Barbara A. Foster, Ekaterina L. Andrianova, Olga V. Chernova,  and Andrei V. Gudkov
1373-1387
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Targeted alpha therapy using astatine (211At)-labeled phenylalanine: A preclinical study in glioma bearing mice

Targeted alpha therapy using astatine (211At)-labeled phenylalanine: A preclinical study in glioma bearing mice

https://doi.org/10.18632/oncotarget.27552

Tadashi Watabe, Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, Yuwei Liu, Kazuhiro Ooe, Takahiro Teramoto, Atsushi Toyoshima, Eku Shimosegawa, Takashi Nakano, Yoshikatsu Kanai, Atsushi Shinohara,  and Jun Hatazawa
1388-1398
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint


Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC